Longeveron mesenchymal stem cells    (DrugBank: -)

1 disease
告示番号疾患名(ページ内リンク)臨床試験数
211左心低形成症候群1

211. 左心低形成症候群 [臨床試験数:20,薬物数:28(DrugBank:9),標的遺伝子数:5,標的パスウェイ数:13
Searched query = "Hypoplastic left heart syndrome", "HLHS"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 20 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT03525418
(ClinicalTrials.gov)
February 21, 201819/2/2018Longeveron Mesenchymal Stem Cells (LMSCs) Delivered During Stage II Surgery for Hypoplastic Left Heart Syndrome (ELPIS)Allogeneic Human MEsenchymal Stem Cell (MSC) Injection in Patients With Hypoplastic Left Heart Syndrome: A Phase I/II Study (ELPIS)HLHSBiological: Longeveron Mesenchymal Stem CellsLongeveron LLCNULLActive, not recruitingN/A1 YearAll30Phase 1;Phase 2United States